// App-Quantinova.ai

: Development of Gray Zone Lymphoma during Remission of Classical Hodgkin Lymphoma

Researchers

Presenter

  • Matthew Nguyen

Principal Investigators

  • Tahmina Jahir

  • Monica Shiffman

  • Maximo Mora

  • Shetra Sivamurthy

Medical Centers

  • Jamaica Hospital Medical Center, Richmond Hill, NY

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Genetic Disorder

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Musculoskeletal

Disease

  • Diffuse large B-cell lymphoma

  • Hodgkin's Lymphoma

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

  • B cell lymphomas

  • Angina

  • Lymphomas

  • Sepsis

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • Cluster of Differentiation 30

Drug/Treatment

  • dacarbazine Intravenous

  • Vinblastine

  • Doxorubicin

  • Enoxaparin

  • Enoxaparin sodium

  • vancomycin capsule

  • Meropenem

  • Bleomycin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved